Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study

Cardiac dysfunction is an important prognostic predictor of cardiovascular mortality in patients on hemodialysis (HD). Erythropoietin (EPO) has been reported to improve cardiac function by binding to the EPO receptor (EPOR) on cardiomyocytes. This study investigated whether anti-EPOR antibodies were...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochida, Yasuhiro, Hara, Akinori, Oka, Machiko, Maesato, Kyoko, Ishioka, Kunihiro, Moriya, Hidekazu, Oshima, Megumi, Toyama, Tadashi, Kitajima, Shinji, Iwata, Yasunori, Sakai, Norihiko, Shimizu, Miho, Koshino, Yoshitaka, Ohtake, Takayasu, Hidaka, Sumi, Kobayashi, Shuzo, Wada, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495431/
https://www.ncbi.nlm.nih.gov/pubmed/36140193
http://dx.doi.org/10.3390/biomedicines10092092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495431/
https://www.ncbi.nlm.nih.gov/pubmed/36140193
http://dx.doi.org/10.3390/biomedicines10092092

Ejemplares similares